𝔖 Bobbio Scriptorium
✦   LIBER   ✦

O53. Development of arylated nitric oxide-releasing prodrugs as anticancer agents

✍ Scribed by Thomas C. Wilde; Joseph E. Saavedra; Paul J. Shami; Victoria F. Findlay; Danyelle M. Townsend; Kenneth D. Tew; Xinhua Ji; Larry K. Keefer


Book ID
116790293
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
65 KB
Volume
14
Category
Article
ISSN
1089-8603

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Synthesis and biological evaluation of f
✍ Yisheng Lai; Lihong Shen; Zhenzhen Zhang; Wenqing Liu; Yihua Zhang; Hui Ji; Jide πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 463 KB

A series of novel furoxan-based nitric oxide (NO)-releasing derivatives of glycyrrhetinic acid (GA) were designed, synthesized, and evaluated for their in vitro cytotoxicity against human hepatocellular carcinoma (HCC) and non-tumor liver cells. Five furoxan/GA hybrids, 7b-d, 7f, and 7g, displayed p